COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy

J Am Acad Dermatol. 2020 Jul;83(1):292-294. doi: 10.1016/j.jaad.2020.04.165. Epub 2020 May 6.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Betacoronavirus / immunology*
  • Betacoronavirus / pathogenicity
  • Biological Products / adverse effects*
  • Biological Products / standards
  • COVID-19
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology
  • Dermatology / standards
  • Female
  • Humans
  • Hygiene / standards
  • Immunotherapy / methods
  • Immunotherapy / standards*
  • Infection Control / standards
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Pandemics / prevention & control*
  • Patient Education as Topic / standards
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / virology
  • Psoriasis / drug therapy*
  • Psoriasis / immunology
  • SARS-CoV-2
  • Societies, Medical / standards
  • Young Adult

Substances

  • Biological Products